MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 54 filers reported holding MARKER THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,077 | -27.5% | 19,089 | +0.0% | 0.00% | – |
| Q3 2022 | $7,000 | +16.7% | 19,084 | -0.0% | 0.00% | – |
| Q2 2022 | $6,000 | -40.0% | 19,087 | -16.4% | 0.00% | – |
| Q1 2022 | $10,000 | -68.8% | 22,840 | -32.4% | 0.00% | – |
| Q4 2021 | $32,000 | -47.5% | 33,800 | -7.0% | 0.00% | – |
| Q3 2021 | $61,000 | -57.3% | 36,343 | -29.1% | 0.00% | – |
| Q2 2021 | $143,000 | +320.6% | 51,225 | +233.5% | 0.00% | – |
| Q1 2021 | $34,000 | -20.9% | 15,360 | -49.4% | 0.00% | – |
| Q4 2020 | $43,000 | +616.7% | 30,348 | +692.6% | 0.00% | – |
| Q3 2020 | $6,000 | -73.9% | 3,829 | -65.1% | 0.00% | – |
| Q2 2020 | $23,000 | +91.7% | 10,979 | +69.9% | 0.00% | – |
| Q1 2020 | $12,000 | -97.8% | 6,462 | -96.6% | 0.00% | – |
| Q4 2019 | $540,000 | -29.3% | 187,315 | +25.4% | 0.00% | – |
| Q3 2019 | $764,000 | +2147.1% | 149,382 | +3353.1% | 0.00% | – |
| Q2 2019 | $34,000 | -53.4% | 4,326 | -61.3% | 0.00% | – |
| Q1 2019 | $73,000 | +151.7% | 11,182 | +113.4% | 0.00% | – |
| Q4 2018 | $29,000 | – | 5,241 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AR ASSET MANAGEMENT INC | 70,700 | $321 | 0.09% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |